Benzinga | Mar 29, 2021 07:27AM EDT

RBC Capital Upgrades PTC Therapeutics to Sector Perform, Announces $47 Price Target

RBC Capital analyst Brian Abrahams upgrades PTC Therapeutics (NASDAQ:PTCT) from Underperform to Sector Perform and announces $47 price target.